Stocks News

LAST PRICE
23.8800
TODAY'S CHANGE (%)
Trending Down-0.6900 (-2.8083%)

Bid / Lots
23.5400/ 1
Ask / Lots
24.4800/ 1
Open / Previous Close
24.3600 / 24.5700
Day Range
Low 23.8600
High 24.3800
52 Week Range
Low 21.5250
High 33.0850
Volume
1,166,291
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 18, 2024
- Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention, from 7:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  7:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  Companies Mentioned: SNN
- Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention, from 7:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  7:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: SNN
  
  Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention
  
  Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,(1) that shows a novel mechanism of action relating to pressure injury prevention (PIP).
Apr 8, 2024
- Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT(TM) solution in Australia, from 6:00PM ET on Monday Apr 08, 2024 by Dow Jones
  6:00PM ET on Monday Apr 08, 2024 by Dow Jones
  Companies Mentioned: SNN
  
  Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT(TM) solution in Australia
  
  Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty
Apr 4, 2024
- Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing, from 1:44PM ET on Thursday Apr 04, 2024 by MT Newswires
  1:44PM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: SNN
  01:44 PM EDT, 04/04/2024 (MT Newswires) -- Smith & Nephew (SNN) said Thursday that the UK National Institute for Health and Care Excellence has reaffirmed its guidance that the company's negative pressure wound dressing be considered an option for c...
- Smith+Nephew's PICO(TM) Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE), from 11:13AM ET on Thursday Apr 04, 2024 by GlobeNewswire
  11:13AM ET on Thursday Apr 04, 2024 by GlobeNewswire
  Companies Mentioned: SNN

Apr 18, 2024
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Business Wire
  9:00AM ET on Thursday Apr 18, 2024 by Business Wire
  Companies Mentioned: BIO.B
Apr 15, 2024
- --Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322, from 10:21AM ET on Monday Apr 15, 2024 by MT Newswires
  10:21AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: BIO
- --Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept, from 8:50AM ET on Monday Apr 15, 2024 by MT Newswires
  8:50AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: TFX
Apr 11, 2024
- Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay, from 5:30PM ET on Thursday Apr 11, 2024 by GlobeNewswire
  5:30PM ET on Thursday Apr 11, 2024 by GlobeNewswire
  Companies Mentioned: BIO.B, OCX
Apr 10, 2024
- Bio-Rad Laboratories COO Andrew Last to Retire in September, from 5:14PM ET on Wednesday Apr 10, 2024 by MT Newswires
  5:14PM ET on Wednesday Apr 10, 2024 by MT Newswires
  Companies Mentioned: BIO
- Bio-Rad's Chief Operating Officer Andrew Last to Retire, from 4:15PM ET on Wednesday Apr 10, 2024 by Business Wire
  4:15PM ET on Wednesday Apr 10, 2024 by Business Wire
  Companies Mentioned: BIO.B
Apr 8, 2024
- RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating, from 7:43AM ET on Monday Apr 08, 2024 by MT Newswires
  7:43AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: BIO
Apr 3, 2024
- --Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400, from 9:01AM ET on Wednesday Apr 03, 2024 by MT Newswires
  9:01AM ET on Wednesday Apr 03, 2024 by MT Newswires
  Companies Mentioned: BIO
- Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024, from 6:00AM ET on Wednesday Apr 03, 2024 by Business Wire
  6:00AM ET on Wednesday Apr 03, 2024 by Business Wire
  Companies Mentioned: PODD
Apr 2, 2024
- Teleflex Incorporated Introduces the UroLift(TM) 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types, from 6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire
  6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire
  Companies Mentioned: TFX

Smith & Nephew PLC
NYSE:SNNUnited States

Search Criteria

Apr 18, 2024

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention, from 7:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention, from 7:00AM ET on Thursday Apr 18, 2024 by Dow Jones

Apr 8, 2024

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT(TM) solution in Australia, from 6:00PM ET on Monday Apr 08, 2024 by Dow Jones

Apr 4, 2024

Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing, from 1:44PM ET on Thursday Apr 04, 2024 by MT Newswires

Smith+Nephew's PICO(TM) Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE), from 11:13AM ET on Thursday Apr 04, 2024 by GlobeNewswire

Peers Headlines

Apr 18, 2024

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Business Wire

Apr 15, 2024

--Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322, from 10:21AM ET on Monday Apr 15, 2024 by MT Newswires

--Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept, from 8:50AM ET on Monday Apr 15, 2024 by MT Newswires

Apr 11, 2024

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay, from 5:30PM ET on Thursday Apr 11, 2024 by GlobeNewswire

Apr 10, 2024

Bio-Rad Laboratories COO Andrew Last to Retire in September, from 5:14PM ET on Wednesday Apr 10, 2024 by MT Newswires

Bio-Rad's Chief Operating Officer Andrew Last to Retire, from 4:15PM ET on Wednesday Apr 10, 2024 by Business Wire

Apr 8, 2024

RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating, from 7:43AM ET on Monday Apr 08, 2024 by MT Newswires

Apr 3, 2024

--Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400, from 9:01AM ET on Wednesday Apr 03, 2024 by MT Newswires

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024, from 6:00AM ET on Wednesday Apr 03, 2024 by Business Wire

Apr 2, 2024

Teleflex Incorporated Introduces the UroLift(TM) 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types, from 6:30AM ET on Tuesday Apr 02, 2024 by GlobeNewswire